Hand-held glucose meters are routinely used for
measuring point of care (POC) glucose in special care nurseries and
emergency departments because of their portability, immediacy of results,
and minimal blood volume requirements. These devices use one of the
following test methods: glucose dehydrogenase pyrroloquinolinequinone (GDH-PQQ),
glucose dehydrogenase nicotinamide adenine dinucleotide (GDH-NAD), glucose
oxidase, or glucose hexokinase methods. Accucheck® (Roche) that uses the
GDH-PQQ method cannot distinguish glucose, maltose, galactose or xylose
from each other, and thus may provide higher anomalous readings. However
MediSense Optium glucose analyzer® and the HemoCue B-Glucose analyzer®
which also utilize GDH are not affected by galactose(1). This has serious
implications and may result in irreversible brain damage following
aggressive insulin treatment for elevated glucose reading(2). We report a
child with classical galactosemia, in which we commenced insulin drip due
to falsely elevated blood sugar levels. Timely thinking for a possibility
of error due to portable glucometers prevented a catastrophe from
happening.
A two-month old infant, product of non-consanguineous
marriage with birth weight of 2.54 kilograms presented with failure to
thrive. Clinical examination revealed a malnourished (weight 2.6 kg),
irritable child with icterus, mild pallor, cataract in the left eye and
firm hepatosplenomegaly. Initial glucose using Accu-check® was elevated
(442 mg/dL). Urine for reducing sugars was strongly positive. Child was
commenced on insulin drip, thinking of a possibility of diabetes mellitus.
There was marked discordance in paired evaluation of sugars using GDH-PQQ
method and laboratory estimations using glucose oxidase method (442 and 91
mg/dL and 391 and 42 mf/dL, respectively).
Other investigations suggested conjugated
hyperbilirubinemia and deranged liver function test (total bilirubin of
5.24 mg/dL, direct bilirubin 4.22 mg/dL, SGOT 195, SGPT 101
alkaline phosphatase 1420). Urine culture grew Escherichia coli. A
diagnosis of galactosemia was anticipated and confirmed by plasma
galactose level of 30 mg/dL and markedly reduced galactose transferase
enzyme levels 2.34 unit/g (normal value 15-30 unit/g).
Epimerase and galactokinase levels were normal. Child showed dramatic
improvement on galactose free diet and was discharged with weight of 3.2
kg.
Hand held glucose meters can have marked variability
ranging from 3.9 to 10.9% in the mid-l00 mg/dL glucose range and
6.2 to 13.3% in the hypoglycemic range(1,3). Reducing sugars such as
galactose, as described in the case above, can interfere with true
readings and paradoxically produce higher readings(1,3). Intravenous
immunoglobulin solutions, oral xylose, and peritoneal dialysis solutions
may contain or be metabolized to maltose, galactose or xylose and thus
interfere with the results of glucometers.
We stress the importance of laboratory confirmation of
all unexpectedly high readings using hand held glucose meters before
initiation of treatment to prevent catastrophes. We also urge the
pediatricians to know the method of estimation of their glucometer.
Acknowledgments
Dr Vinod Chaudhury and Dr Vivek Goswami, Department of
Pediatrics at Fortis hospital, Noida and Dr Pankaj Garg at Sitaram Bhartia
Institute of Science and Research for help in drafting.
References
1. Newman JD, Ramsden C, Balazs ND. Monitoring
neonataI hypoglycemia with the Accu-chek advantage II glucose meter: The
cautionary tale of galactosaemia. Clin Chern 2002; 48: 2071.
2. US Food and Drug Administration: FDA reminders for
falsely elevated glucose readings from use of inappropriate test method,
2005. Available from http://eee.fda.gov/cdrh/oivd/news/glucosefalse.htm.
Accessed 10 July, 2007.
3. Hyde P, Betts P. Galactosaemia presenting as bedside hyperglycaemia.
J Paediatr Child Health 2006; 42: 659.